![]() |
For those interested in covid vaccine reactogenicity...
from CDC web site based upon data from trials supporting EUA: Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Moderna COVID-19 Vaccine: https://www.cdc.gov/vaccines/covid-19/info-by-product/moderna/reactogenicity.html Local Reactions, Systemic Reactions, Adverse Events, and Serious Adverse Events: Pfizer-BioNTech COVID-19 Vaccine https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html Some things to note: This data comes from trials and subsequently from the FDA briefing sheets, and there are links to these at both sites. Everything is based on subject (patient) reporting. Information on the specifics of trial forms, instructions and procedures for collection of these data and for reducing the pools into useful information is ilkely in the public domain. Comparisosn are between vaxed and placebo (placebo control). Also remember these studies were blinded. Tables 3 and 4 provide systemic reaction information (64 and under and 65+). Note the sizes of the data sets. |
For those interested in ways the gubmint tries to track reports of vaccine reactogenicity, and/or adverse events...
The companies with EUA or licensed (aka "approved) vaccine, there are extensive ongoing regulatory requirements in the CFR, and FDA monitors compliance. This is true for medical devices and equipment as well. There are other parallel programs for information gathering and mining. For example, for vaccines, CDC/FDA have a had a special program for several decades: CDC VAERS About VAERS: https://wonder.cdc.gov/wonder/help/vaers.html# Remember: VAERS data collection is "wide open." I imagine that there may be some cybersecurity tools in place, but basically it looks like anyone can report anything. The procedures, methods, tools, forms, instructions, et cetera used by manufacturers as they collect data to support EUA and likely later approval, are almost certainly far more rigorous than a "wide open" tool like VAERS. May be important for some folks to understand that. It can be helpful to consider the VAERS disclaimer on this page: https://wonder.cdc.gov/VAERS.html Here is a video on generating VAERS reports: https://www.youtube.com/watch?v=cOH7cFWS7o4&t=637s |
Quote:
Alcohol is only a problem for those that got the shot with the microchip in it. Thought everyone knew that. |
For those interested in historic experiences with vaccines related to "roll out,"
You may find this interesting: https://abcnews.go.com/Health/covid-19-vaccine-rollout-compares-smallpox-polio-past/story?id=75489514 I did not previously know about the "Cutter Incident." I think I remember consuming that sugar cube. For more: see also, e.g., https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1383764/ And I quote: "The Cutter incident had an ambivalent legacy. On the one hand, it led to the effective federal regulation of vaccines, which today enjoy a record of safety `unmatched by any other medical product'. On the other hand, the court ruling that Cutter was liable to pay compensation to those damaged by its polio vaccine—even though it was not found to be negligent in its production—opened the floodgates to a wave of litigation. As a result, `vaccines were among the first medical products almost eliminated by lawsuits'. Indeed, the National Vaccine Injury Compensation Program was introduced in 1986 to protect vaccine manufacturers from litigation on a scale that threatened the continuing production of vaccines. Still, many companies have opted out of this low-profit, high-risk field, leaving only a handful of firms to meet a growing demand (resulting in recent shortages of flu and other vaccines)." Even CDC gives historical perspective: https://www.cdc.gov/vaccinesafety/concerns/concerns-history.html Vaccine business = "challenging" With vaccines, drugs, devices and equipment, there are a lot of regs. I have witnessed about 40 years of evolution with respect to the latter two categories. And I have worked with a lot of lawyers... If I recall correctly way back when I was working for a large company that made and sold CAT scanners we were part of a lawsuit that I think asserted that our machine's x-rays caused a psychic to "lose her abilities." PITA... but "Nothing comes amiss so money comes withal." (Grumio) Anyway, I now have even more respect for the two people I know that are vaccine industry veterans. |
You can use this link to sort the actual reports by vaccine, age, location, hospitalized, died, etc.
https://medalerts.org/vaersdb/index.php |
Quote:
Direct query of VAERS is at https://wonder.cdc.gov/controller/datarequest/D8 SmileWavy |
Quote:
|
Quote:
|
Quote:
Can I pull up similar info such as this? http://forums.pelicanparts.com/uploa...1617796542.jpg |
Got my first 5g... I mean pfizer shot 2 days ago. Woke at 3am, with bad shoulder ache, slept in two hours longer than usual. Sick and tired all day, worsening, working but spacy. Headache, ringing ears, sore mouth, nausia and fatigue. Still dont feel great but much better today. Wife had her second on same day and she was shivering and knocked out on the couch all afternoon.
When my parents got it they had no immune response - we joke that they got the placebo. PS: Read whole thread and feeling ripped off, it has none of the entertainment value of the other pelican 'rona discussions. |
What happens when mRNA hits the wrong target ...
http://forums.pelicanparts.com/uploa...1618726711.jpg |
|
Quote:
Quote:
|
Remember the doctor who lost all this platelets ? That's thrombocytopenia.
https://www.the-sun.com/news/2305200/doctor-dies-36-others-develop-rare-blood-disorder-vaccines/ Just three days after he received the Pfizer vaccine, Dr. Gregory Michael, 56, of Miami Beach developed symptoms for immune thrombocytopenia, a rare blood disorder that stops the creation of platelets, which are necessary for clotting. Luz Legaspi, 72, woke up to find bruises on her arms and legs and bleeding blisters in her mouth just a day after receiving her first dose of the Moderna vaccine. ... 39 persons with a newly described syndrome characterized by thrombosis and thrombocytopenia that developed 5 to 24 days after initial vaccination with ChAdOx1 nCoV-19 (AstraZeneca), a recombinant chimpanzee adenoviral vector encoding the spike protein of SARS-CoV-2.3-5 These persons were healthy or in medically stable condition, and very few were known to have had previous thrombosis or a preexisting prothrombotic condition. Most of the patients included in these reports were women younger than 50 years of age, some of whom were receiving estrogen-replacement therapy or oral contraceptives. A remarkably high percentage of the patients had thromboses at unusual sites — specifically, cerebral venous sinus thrombosis or thrombosis in the portal, splanchnic, or hepatic veins. Other patients presented with deep venous thrombi, pulmonary emboli, or acute arterial thromboses. The median platelet counts at diagnosis were approximately 20,000 to 30,000 per cubic millimeter (range, approximately 10,000 to 110,000), but the rate of decline in platelet counts that preceded thrombosis is unknown. High levels of d-dimers and low levels of fibrinogen were common and suggest systemic activation of coagulation. Approximately 40% of the patients died, some from ischemic brain injury, superimposed hemorrhage, or both conditions, often after anticoagulation. What component or components of the vaccine (adenoviral sequence, spike protein, or other component) elicit a new (or recall) response to a seemingly unrelated host protein, PF4? NEJM |
|
In most ways, the mRNA Vaccines are better than natural infection in anti-body response.
https://www.news-medical.net/news/20210421/Antibody-response-induced-by-mRNA-vaccination-differs-from-natural-SARS-CoV-2-infection.aspx |
All times are GMT -8. The time now is 05:16 PM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2025, vBulletin Solutions, Inc.
Search Engine Optimization by vBSEO 3.6.0
Copyright 2025 Pelican Parts, LLC - Posts may be archived for display on the Pelican Parts Website